PX
58
3
FIS
48
2
UNM
71
3
AES
49
-5
TSCO
48
5
LB
18
9
TJX
55
7
RCL
74
-2
STX
73
-8
CNX
37
-16
EIX
43
3
URI
70
10
RIG
50
-5
KO
46
4
PSX
72
7
ESS
31
3
SHW
45
3
AEP
67
6
IR
66
11
GRMN
43
3
PX
58
3
FIS
48
2
UNM
71
3
AES
49
-5
TSCO
48
5
LB
18
9
TJX
55
7
RCL
74
-2
STX
73
-8
CNX
37
-16
EIX
43
3
URI
70
10
RIG
50
-5
KO
46
4
PSX
72
7
ESS
31
3
SHW
45
3
AEP
67
6
IR
66
11
GRMN
43
3
Financhill
Back

PIMCO Corporate & Income Opportunity Fund Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Sell
49

PTY
PIMCO Corporate & Income Opportunity Fund

Last Price:
$13.18
Seasonality Move:
-0.57%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$54.98
Seasonality Move:
-11.9%
Sell
49
PIMCO Corporate & Income Opportunity Fund (PTY) is a Sell

Is PIMCO Corporate & Income Opportunity Fund a Buy, Sell or Hold?

  • The current PIMCO Corporate & Income Opportunity Fund [PTY] share price is $13.16. The Score for PTY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • PTY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTY Stock Price Chart

What is PIMCO Corporate & Income Opportunity Fund's stock price today?

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

PTY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 56.28 Buy
Chaikin Money Flow: 592211 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.86 - 13.14) Buy
Bollinger Bands (100): (13.14 - 14.3) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

PTY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.03 Buy
20-day SMA: 12.96 Buy
50-day SMA: 13.21 Sell
200-day SMA: 13.74 Sell
8-day EMA: 13.06 Buy
20-day EMA: 13.03 Buy
50-day EMA: 13.24 Sell
200-day EMA: 13.74 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

PIMCO Corporate & Income Opportunity Fund Earnings Growth & PTY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

PIMCO Corporate & Income Opportunity Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):